Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference News provided by Generate:Biomedicines May 28, 2026, 16:20 ET Share this article Share to X Share this article Share to X SOMERVILLE, Mass. , May 28, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (NASDAQ: GENB ) today announced that it intends to participate in the Goldman Sachs Global Healthcare Conference on Monday, June 8, 2026. A live webcast is expected to be available in the Events and Presentations section of the Company's investor website at investors.generatebiomedicines.com . An archived replay is also expected to be available following the presentation. About Generate:Biomedicines Generate (NASDAQ: GENB ) is a clinical-stage generative biology company founded at the intersection of machine learning, biological engineering, and medicine, advancing a new era of programmable biology to engineer better medicines for patients, faster. The Generate Platform integrates computational design with large-scale biological experimentation, enabling the creation of novel, optimized therapeutics that address historically undruggable and hard-to-drug targets, as well as known targets in new and more effective ways. The platform has enabled the generation of a broad pipeline of therapies across multiple therapeutic areas and protein-based modalities, addressing health challenges out of reach of traditional approaches. Founded in 2018, Generate is leading a fundamental shift from drug discovery to drug generation. Learn more at www.generatebiomedicines.com, or follow us on X, LinkedIn, and YouTube. Generate Media Contact Megan McLaughlin [email protected] SOURCE Generate:Biomedicines 21 % more press release views with Request a Demo × Modal title